Announcement on behalf of OBIGEN that its institutional director changes its representative

Announcement on behalf of OBIGEN the resignation of Chairperson

Announcement on behalf of OBIGEN of the resignation of its institutional director

Announcement of 2024 Consolidated Financial Statements were approved by the Board of Directors

The Company's Board of Directors resolved to convene the 2025 Annual General Shareholders' Meeting

Announcement on behalf of Amaran’s BOD to resolve the reference date for conversion of employee stock options to common shares

Announcement on behalf of Amaran that the BOD resolved to issue 2025 employee stock options and the subscription rules

Announcement for the expected date of the Board of Directors Meeting for 2024 financial reports is 2025/03/10

Announcement on behalf of OBIGEN Pharma the new appointment of CEO

Announcement on behalf of OBIGEN Pharma of the BOD’s resolution to lift the non-competition restrictions for CEO